{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:04:53Z","timestamp":1758636293717,"version":"3.32.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,8,1]],"date-time":"1993-08-01T00:00:00Z","timestamp":744163200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[1993,8]]},"DOI":"10.1007\/bf00916582","type":"journal-article","created":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T04:30:39Z","timestamp":1104553839000},"page":"417-425","source":"Crossref","is-referenced-by-count":11,"title":["Comparison of in vitro effects of flunixin and tolfenamic acid on human leukocyte and platelet functions"],"prefix":"10.1007","volume":"17","author":[{"given":"H.","family":"Kankaanranta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Vapaatalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"935","volume-title":"Inflammation: Basic Principles and Clinical Correlates","author":"I. M. Goldstein","year":"1988","unstructured":"Goldstein, I. M. 1988. Agents that interfere with arachidonic acid metabolism,In Inflammation: Basic Principles and Clinical Correlates. J. I. Gallin, I. M. Goldstein, and R. Snyderman, editors. Raven Press, New York. 935?946."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/anr.1780320102","volume":"32","author":"S. B. Abramson","year":"1989","unstructured":"Abramson, S. B., andG. Weissmann. 1989. The mechanism of action of nonsteroidal antiinflammatory drugs.Arthritis Rheum. 32:1?9.","journal-title":"Arthritis Rheum."},{"key":"CR3","first-page":"305","volume-title":"Antiinflammatory Drugs, Handbook of Experimental Pharmacology, Vol. 50\/II","author":"T. Y. Shen","year":"1979","unstructured":"Shen, T. Y. 1979. Prostaglandin synthetase inhibitors I.In Antiinflammatory Drugs, Handbook of Experimental Pharmacology, Vol. 50\/II. J. R. Vane, and S. H. Ferreira, editors. Springer-Verlag, Berlin. 305?347."},{"key":"CR4","first-page":"348","volume-title":"Antiinflammatory Drugs, Handbook of Experimental Pharmacology, Vol. 50\/11","author":"S. H. Ferreira","year":"1979","unstructured":"Ferreira, S. H., andJ. R. Vane. 1979. Mode of action of antiinflammatory agents which are prostaglandin synthetase inhibitors.In Antiinflammatory Drugs, Handbook of Experimental Pharmacology, Vol. 50\/11. J. R. Vane, and S. H. Ferreira, editors. Springer-Verlag, Berlin. 348?398."},{"key":"CR5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/BF02028298","volume":"24","author":"E. Moilanen","year":"1988","unstructured":"Moilanen, E., J. Alanko, E. Sepp\ufffdl\ufffd, andH. Vapaatalo. 1988. Effects of antirheumatic drugs on leukotriene B4 and prostanoid synthesis in human polymorphonuclear leukocytes in vitro.Agents Actions 24:387?394.","journal-title":"Agents Actions"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02022985","volume":"28","author":"E. Moilanen","year":"1989","unstructured":"Moilanen, E., J. Alanko, A. Juhakoski, andH. Vapaatalo. 1989. Orally administered tolfenamic acid inhibits leukotriene synthesis in isolated human peripheral polymorphonuclear leukocytes.Agents Actions 28:83?88.","journal-title":"Agents Actions"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF00917508","volume":"15","author":"H. Kankaanranta","year":"1991","unstructured":"Kankaanranta, H., E. Moilanen, andH. Vapaatalo. 1991. Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.Inflammation 15:137?143.","journal-title":"Inflammation"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0034-5288(18)30505-8","volume":"40","author":"M. M. Hardee","year":"1986","unstructured":"Hardee, M. M., andJ. N. Moore. 1986. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.Res. Vet. Sci. 40:152?156.","journal-title":"Res. Vet. Sci."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0034-5288(18)31876-9","volume":"37","author":"P. Lees","year":"1984","unstructured":"Lees, P., andA. J. Higgins. 1984. Flunixin inhibits prostaglandin E2 production in equine inflammation.Res. Vet. Sci. 37:347?349.","journal-title":"Res. Vet. Sci."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2885.1990.tb00767.x","volume":"13","author":"H. Str\ufffdm","year":"1990","unstructured":"Str\ufffdm, H., andM. Krogsgaard Thomsen. 1990. Effects of nonsteroidal antiinflammatory drugs on canine neutrophil chemotaxis.J. Vet. Pharmacol. Ther. 13:186?191.","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"CR11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00914089","volume":"14","author":"R. D. Zwahlen","year":"1990","unstructured":"Zwahlen, R. D., D. R. Roth, andM. Wyder-Walther. 1990. In vitro aggregation of bovine neonatal neutrophils. A comparative study with adult cattle.Inflammation 14:375?387.","journal-title":"Inflammation"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2885.1987.tb00092.x","volume":"10","author":"J. Dawson","year":"1987","unstructured":"Dawson, J., P. Lees, andA. D. Sedowick. 1987. Actions of nonsteroidal antiinflammatory drugs on equine leukocyte movement in vitro.J. Vet. Pharmacol. Ther. 10:150?159.","journal-title":"J. Vet. Pharmacol. Ther."},{"issue":"suppl","key":"CR13","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-3083.1976.tb03851.x","volume":"5","author":"A. B\ufffdyum","year":"1976","unstructured":"B\ufffdyum, A. 1976. Isolation of lymphocytes, granulocytes and macrophages.Scand. J. Immunol. 5(suppl):9?15.","journal-title":"Scand. J. Immunol."},{"key":"CR14","first-page":"1","volume-title":"Selected Methods in Cellular Immunology","author":"B. B. Mishell","year":"1980","unstructured":"Mishell, B. B., andS. M. Shiigi. 1980. In vitro immune responses.In Selected Methods in Cellular Immunology. B. B. Mishell and S. M. Shiigi, editors. W. H. Freeman and Company, San Francisco. 1?166."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4049\/jimmunol.110.1.233","volume":"110","author":"J. I. Gallin","year":"1973","unstructured":"Gallin, J. I., R. A. Clark, andH. R. Kimball. 1973. Granulocyte chemotaxis: an improved in vitro assay employing51Cr-labeled granulocytes.J. Immunol. 110:233?240.","journal-title":"J. Immunol."},{"key":"CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0262-1746(84)90207-5","volume":"14","author":"E. Sepp\ufffdl\ufffd","year":"1984","unstructured":"Sepp\ufffdl\ufffd, E., O. Pora, andT. Mets\ufffd-Ketel\ufffd. 1984. A modified method for extraction and purification of prostaglandins with resin XAD-2.Prostaglandins Leukotrienes Med. 14:235?241.","journal-title":"Prostaglandins Leukotrienes Med."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0262-1746(86)90190-3","volume":"23","author":"A. M. Boctor","year":"1986","unstructured":"Boctor, A. M., M. Eickholt, andT. A. Pugsley. 1986. Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro.Prostaglandins Leukolrienes Med. 23:229?238.","journal-title":"Prostaglandins Leukolrienes Med."},{"key":"CR18","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/art.1780300909","volume":"30","author":"H. D. Perez","year":"1987","unstructured":"Perez, H. D., F. Elfman, andS. Marder. 1987. Meclofenamate sodium monohydrate inhibits chemotactic factor-induced human polymorphonuclear leukocyte function.Arthritis Rheum. 30:1023?1031.","journal-title":"Arthritis Rheum."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1055\/s-2008-1048097","volume":"9","author":"R. Fruchtmann","year":"1984","unstructured":"Fruchtmann, R., U. Krupka, andB. Pelster. 1984. Hemmung des Lipoxygenase- und Cyclooxygenaseweges im Arachidons\ufffdure-Metabolismus durch Etofenamat.Aktuel Rheumatol. 9:165?168.","journal-title":"Aktuel Rheumatol."},{"issue":"suppl","key":"CR20","first-page":"58","volume":"85","author":"H. Kankaanranta","year":"1990","unstructured":"Kankaanranta, H., E. Moilanen, A.-L. Kirkkola, andH. Vapaatalo. 1990. NSAIDs and neutrophil functions: Effects of mefenamic and tolfenamic acids.Scand. J. Rheumatol. 85(suppl):58.","journal-title":"Scand. J. Rheumatol."},{"key":"CR21","first-page":"155","volume":"15","author":"G. D. Bottoms","year":"1985","unstructured":"Bottoms, G. D., M. A. Johnson, C. H. Lamar, J. F. Fessler, andJ. J. Turek. 1985. Endotoxin-induced eicosanoid production by equine vascular endothelial cells and neutrophils.Circ. Shock 15:155?162.","journal-title":"Circ. Shock"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0090-6980(87)90088-8","volume":"34","author":"M. J. Forrest","year":"1987","unstructured":"Forrest, M. J., D. Burton, andP. M. Brooks. 1987. The metabolism of synthetic leukotriene B4 in synovial fluid and whole human blood.Prostaglandins 34:433?443.","journal-title":"Prostaglandins"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01993255","volume":"34","author":"K. E. Proudman","year":"1991","unstructured":"Proudman, K. E., andR. M. Mcmillan. 1991. Are tolfenamic acid and tenidap dual inhibitors of 5-lipoxygenase and cyclooxygenase?Agents Actions 34:121?124.","journal-title":"Agents Actions"},{"issue":"suppl 28","key":"CR24","first-page":"6","volume":"18","author":"J. F. Fries","year":"1991","unstructured":"Fries, J. F. 1991. NSAID gastropathy: The second most deadly rheumatic disease? Epidemiology and risk appraisal.J. Rheumatol. 18(suppl 28):6?10.","journal-title":"J. Rheumatol."},{"issue":"suppl 163","key":"CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/00365528909091169","volume":"24","author":"K. D. Rainsford","year":"1989","unstructured":"Rainsford, K. D. 1989. Mechanism of gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs.Scand. J. Gastroenterol. 24(suppl 163):9?16.","journal-title":"Scand. J. Gastroenterol."},{"key":"CR26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-114-4-307","volume":"114","author":"A. H. Soll","year":"1991","unstructured":"Soll, A. H., W. M. Weinstein, J. Kurata, andD. Mccarthy. 1991. Nonsteroidal antiinflammatory drugs and peptic ulcer disease.Ann. Intern. Med. 114:307?319.","journal-title":"Ann. Intern. Med."},{"key":"CR27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-6147(92)90046-9","volume":"13","author":"J. L. Wallace","year":"1992","unstructured":"Wallace, J. L., andD. N. Granger. 1992. Pathogenesis of NSAID gastropathy: Are neutrophils the culprits?Trends Pharmacol Sci. 13:129?131.","journal-title":"Trends Pharmacol Sci."},{"key":"CR28","first-page":"195","volume":"53","author":"J. B. Carrick","year":"1989","unstructured":"Carrick, J. B., M. G. Papich, D. M. Middleton, J. M. Naylor, andH. G. G. Townsend. 1989. Clinical and pathological effects of flunixin meglumine administration to neonatal foals.Can. J. Vet. Res. 53:195?201.","journal-title":"Can. J. Vet. Res."},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2460\/ajvr.1990.51.07.1131","volume":"51","author":"S. W. Dow","year":"1990","unstructured":"Dow, S. W., R. A. Rosychuk, A. E. Mcchesney, andC. R. Curtis. 1990. Effects of flunixin and flunixin plus prednisone on the gastrointestinal tract of dogs.Am. J. Vet. Res. 51:1131?1138.","journal-title":"Am. J. Vet. Res."},{"key":"CR30","first-page":"358","volume":"29","author":"T. Yamaura","year":"1982","unstructured":"Yamaura, T., T. Numoto, andK. Tosaka. 1982. A new experimental model for analysis of gastrointestinal injuries induced by acid non-steroidal antiinflammatory agents (ANSAIC).J. Med. Soc. Toho. Univ. 29:358?384.","journal-title":"J. Med. Soc. Toho. Univ."},{"key":"CR31","first-page":"23","volume":"6","author":"C. K. Axelsson","year":"1977","unstructured":"Axelsson, C. K., L. V. Christiansen, Aa. Johansen, andP. E. Poulsen. 1977. Comparative effects of tolfenamic acid and acetylsalicylic acid on human gastric mucosa. A double blind crossover trial employing gastroscopy, extern gastrocamera and multiple biopsies.Scand. J. Rheumatol. 6:23?27.","journal-title":"Scand. J. Rheumatol."},{"issue":"suppl","key":"CR32","first-page":"59","volume":"85","author":"A. Kivinen","year":"1990","unstructured":"Kivinen, A., E. Moilanen, andH. Vapaatalo. 1990. Tolfenamic acid prevents ethanol- or acetylsalicylic acid-induced gastric ulcers in the rat.Scand. J. Rheumatol. 85(suppl):59.","journal-title":"Scand. J. Rheumatol."},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1002\/art.1780341103","volume":"34","author":"J. F. Fries","year":"1991","unstructured":"Fries, J. F., C. A. Williams, andD. A. Block. 1991. The relative toxicity of nonsteroidal antiinflammatory drugs.Arthritis Rheum. 34:1353?1360.","journal-title":"Arthritis Rheum."},{"key":"CR34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-114-4-257","volume":"114","author":"M. R. Griffin","year":"1991","unstructured":"Griffin, M. R., J. M. Piper, J. R. Dauoherty, M. Snowden, andW. A. Ray. 1991. Nonsteroidal antiinflammatory drug use and increased risk for peptic ulcer disease in elderly persons.Ann. Intern. Med. 114:257?263.","journal-title":"Ann. Intern. Med."},{"key":"CR35","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/vr.124.25.651","volume":"124","author":"Q. A. Mckellar","year":"1989","unstructured":"Mckellar, Q. A., E. A. Galbraith, J. A. Booan, C. S. Russell, R. E. Hooke, andP. Lees. 1989. Flunixin pharmacokinetics and serum thromboxane inhibition in the dog.Vet. Rec. 124:651?654.","journal-title":"Vet. Rec."},{"key":"CR36","first-page":"172","volume":"47","author":"I. B. Johnstone","year":"1983","unstructured":"Johnstone, I. B. 1983. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.Can. J. Comp. Med. 47:172?179.","journal-title":"Can. J. Comp. Med."},{"key":"CR37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/01.ATV.5.1.2","volume":"5","author":"M. B. Zucker","year":"1985","unstructured":"Zucker, M. B., andV. T. Nachmias. 1985. Platelet activation.Arteriosclerosis 5:2?18.","journal-title":"Arteriosclerosis"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00916582.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00916582\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00916582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T04:25:13Z","timestamp":1734841513000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00916582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,8]]}},"alternative-id":["BF00916582"],"URL":"https:\/\/doi.org\/10.1007\/bf00916582","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"type":"print","value":"0360-3997"},{"type":"electronic","value":"1573-2576"}],"subject":[],"published":{"date-parts":[[1993,8]]}}}